FIGS, Inc. (NYSE: FIGS) stock is soaring 16.27% in pre-market trading on Friday, following the release of its impressive third-quarter 2025 financial results, an optimistic outlook for the full year, and positive analyst reactions. The healthcare apparel maker significantly outperformed analyst expectations, demonstrating robust growth and improved profitability.
FIGS reported quarterly earnings of $0.05 per share, surpassing the analyst consensus estimate of $0.02 by 212.5%. This marks a substantial turnaround from the $0.01 loss per share reported in the same period last year. The company's revenue also beat expectations, coming in at $151.7 million, 6.42% above the analyst consensus estimate and representing an 8.2% year-over-year increase. Net income surged to $8.7 million, compared to a net loss of $1.7 million in the prior-year quarter. Looking ahead, FIGS raised its full-year 2025 outlook, projecting net revenue growth of about 7.0%, up from its previous forecast of low single-digit growth. The company also increased its adjusted EBITDA margin guidance to approximately 10.3% from the previous range of 8.5%-9%.
The strong quarterly results and improved outlook have prompted positive reactions from Wall Street analysts. Telsey Advisory Group raised its price target on FIGS to $9 from $7, while maintaining a Market Perform rating. BTIG reiterated its Buy rating on the stock. Even Goldman Sachs, which maintains a Sell rating, raised its price target to $5.50 from $5. The combination of better-than-expected financial performance, raised guidance, and favorable analyst sentiment has fueled investor optimism, contributing to the stock's significant pre-market surge.
Comments